Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

Data was presented today byAstraZeneca, at the European Atherosclerosis Society (EAS) Congress in France,on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL-C reduction on top of statin in Phase I trial.

News | Cardiovascular Clinical Studies

Oral PCSK9 Inhibitor Demonstrated Significant LDL-C Reduction on Top of Statin in Phase I Trial Presented at EAS Congress

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

May 29, 2024

Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024

News | Heart Failure

Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

May 28, 2024

The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading.

News | AHA

American Heart Association Warns of Misinformation Connecting COVID Vaccination to Heart Defects

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

May 24, 2024

Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1

News | Pharmaceuticals

New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

May 24, 2024

Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa

News | EP Lab

Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

May 21, 2024

$Early Cardiac Resynchronization Therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB), according to a study conducted by a research team led by Yong-Mei Cha, MD, cardiac electrophysiologist at Mayo Clinic, Rochester, MN, presented during the Heart Rhythm Society meeting, HRS 2024.$

News | HRS

Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure

May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and ...

May 18, 2024

Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker

News | Cardiovascular Clinical Studies

MODULAR ATP Study of the mCRM System Meets Primary Safety and Efficacy Endpoints

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

May 18, 2024

During the Heart Rhythm Society (HRS) annual meeting, HRS 2024, findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), for patients with atrial fibrillation (AF) were presented. Learn more of the late-breaking science from the FARADISE, admIRE Study, and Advent Trial here.

News | HRS

Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety ...

May 18, 2024

Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs

News | Cardiovascular Clinical Studies

Philips Presents Study Results at Heart Rhythm Annual Meeting Demonstrating Benefits of its AI-powered Cardiac Monitoring Solutions

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...

May 17, 2024

Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions

News | Cardiovascular Clinical Studies

Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes/Heart Failure

May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...

May 17, 2024

Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling medical teams to intervene and avoid hospitalization.

News | FDA

Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm

May 17, 2024 — Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has ...

May 17, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

News | Peripheral Artery Disease (PAD)

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...

May 16, 2024

A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart

News | Cardiovascular Clinical Studies

Transcatheter Valve Replacement Outcomes Similar to Surgery in Long-Term Analysis

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

May 15, 2024

CardioFocus will feature its portfolio of innovative ablation systems which optimize lesion creation via confirmed tissue contact and sophisticated energy delivery

News

CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

May 15, 2024

STEP-HFpEF analysis presented in a late breaking science session today at Heart Failure 2024

News | Cardiovascular Clinical Studies

Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients

May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms ...

May 13, 2024